Evidence map›Paper›PMID 36989327›Full record

ArticlePloS one2023

Precision engineering of biological function with large-scale measurements and machine learning.

Drew S Tack, Peter D Tonner, Abe Pressman, Nathan D Olson, Sasha F Levy, Eugenia F Romantseva, Nina Alperovich, Olga Vasilyeva, David Ross

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Drew S TackNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.ORCID 0000-0002-9380-4643
Peter D TonnerNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.
Abe PressmanNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.
Nathan D OlsonNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.ORCID 0000-0003-2585-3037
Sasha F LevySLAC National Accelerator Laboratory, Menlo Park, CA, United States of America.
Eugenia F RomantsevaNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.
Nina AlperovichNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.
Olga VasilyevaNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.
David RossNational Institute of Standards and Technology, Gaithersburg, MD, United States of America.ORCID 0000-0002-7790-218X
National Institute of Standards and Technology · USSLAC National Accelerator Laboratory · US

Funding

Multiplexed In Vivo DNA AssemblyR01HG011676 · NHGRI · STANFORD UNIVERSITY · PI LEVY, SASHA F · 2022 to 2024
$2.9M
PPiSeq: High-Throughput Protein-Protein Interaction SequencingR01AI164530 · NIAID · STANFORD UNIVERSITY · PI SHERLOCK, GAVIN J · 2021 to 2024
$1.7M
PPiSeq: High-Throughput Protein-Protein Interaction SequencingR01HG008354 · NHGRI · STATE UNIVERSITY NEW YORK STONY BROOK · PI LEVY, SASHA F · 2015 to 2018
$1.5M
NHGRI NIH HHS R01 HG008354NHGRI NIH HHS R01 HG011676NIAID NIH HHS R01 AI164530
6 · The paper itself

Abstract

As synthetic biology expands and accelerates into real-world applications, methods for quantitatively and precisely engineering biological function become increasingly relevant. This is particularly true for applications that require programmed sensing to dynamically regulate gene expression in response to stimuli. However, few methods have been described that can engineer biological sensing with any level of quantitative precision. Here, we present two complementary methods for precision engineering of genetic sensors: in silico selection and machine-learning-enabled forward engineering. Both methods use a large-scale genotype-phenotype dataset to identify DNA sequences that encode sensors with quantitatively specified dose response. First, we show that in silico selection can be used to engineer sensors with a wide range of dose-response curves. To demonstrate in silico selection for precise, multi-objective engineering, we simultaneously tune a genetic sensor's sensitivity (EC50) and saturating output to meet quantitative specifications. In addition, we engineer sensors with inverted dose-response and specified EC50. Second, we demonstrate a machine-learning-enabled approach to predictively engineer genetic sensors with mutation combinations that are not present in the large-scale dataset. We show that the interpretable machine learning results can be combined with a biophysical model to engineer sensors with improved inverted dose-response curves.

Indexed as

Machine LearningSynthetic Biology

Identifiers

PMID36989327
PMCPMC10057847
OpenAlexW4361283325

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.